Increased expression of insulin-like growth factors in progressive glomerulonephritis of the MRL lpr mouse

Abstract

Glomerulonephritisis an important complication of systemic lupus erythematosus (SLE). The tissue distribution and exact role of the insulin-like growth factors (IGFs) in the development of lupus nephritis in the MRL/lpr mouse model have not been established. The present study was undertaken to evaluate the changes over time in mRNA and peptide expression of IGF-I and IGFBP-2 in the MRL/lpr mouse. Using in situ hybridizationand immunocytochemistrytechniques, the expressionof IGF-I and IGFBP-2 in MRL/lpr mouse was examined and compared to their congenic normal MRL- mouse counterparts from nine to 24 weeks of age. In the MRL- and MRL/lpr mouse kidneys, IGF-I and IGFBP-2 mRNA expression was limited to the cortical and medullary collecting ducts, while their immunoreactivity (IR) was localized to the cortical and medullary collecting ducts, loop of Henle, glomeruli and proximal tubules. Over time, and with progression of disease, the MRL/lpr mice displayed a significant increase in IGF-I IR and a modest increase in IGFBP-2 IR within the outer cortical glomeruli, which was associated with a significant increase in glomerulosclerosis and glomerular cell proliferation and with a significant decrease in renal function. In conclusion, this overexpression of IGF-I and IGFBP-2 within the glomeruli of the MRL/lpr mouse kidney supports their potential role in the alterations in renal function and morphology that accompany lupus nephritis.

Keywords

glomerulonephritis IGF-I IGFBP-2 MRL/lpr

Get full access to this article

View all access options for this article.

References

Klinman DM , Steinberg AD. Systemic autoimmune disease arises from polyclonal B cell activation . J Exp Med 1987; 165: 1755-1760 .

Foster MH , Kelley VR. Lupus nephritis: update on pathogenesis and disease mechanisms . Semin Nephrol 1999; 19: 173-181 .

Kelley VR , Wuthrich RP. Cytokines in the pathogenesis of systemic lupus erythematosus . Semin Nephrol 1999; 19: 57-66 .

Kiberd BA. The functional and structural changes of the glomerulus throughoutthe course of murine lupus nephritis . J Am Soc Nephrol 1992; 3: 930-939 .

Theofilopoulos AN , Dixon FJ. Murine models of systemic lupus erythematosus . Adv Immunol 1985; 37: 269-390 .

Andrews BS , Eisenberg RA , Theofilopoulos AN et al. Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains . J Exp Med 1978; 148: 1198-1215 .

Eisenberg RA , Sobel ES , Reap EA et al. The role of B cell abnormalities in the systemic autoimmune syndromes of lpr and gld mice . Semin Immunol 1994; 6: 49-54 .

Yamamoto K , Loskutoff DJ. Expression of transforming growth factor-beta and tumor necrosis factor-alpha in the plasma and tissues of mice with lupus nephritis . Lab Invest 2000; 80: 1561-1570 .

Schneider MR , Lahm H , Wu M et al. Transgenic mouse models for studying the functions of insulin-like growth factor-binding proteins . FASEB J 2000; 14: 629-640 .

10.

Nakamura T , Ebihara I , Fukui M et al. Messenger RNA expression for growth factors in glomeruli from focal glomerular sclerosis . Clin Immunol Immunopathol 1993; 66: 33-42 .

11.

Nakamura T , Ebihara I , Nagaoka I et al. Effect of methylprednisoloneon transforming growth factor-beta, insulin-like growth factor-I, and basic fibroblast growth factor gene expression in the kidneys of NZB/W F1 mice . Ren Physiol Biochem 1993; 16: 105-116 .

12.

Schreiber BD , Hughes ML , Groggel GC. Insulin-like growth factor-1 stimulates production of mesangial cell matrix components . Clin Nephrol 1995; 43: 368-374 .

13.

Feld SM , Hirschberg R , Artishevsky A et al. Insulin-like growth factor I induces mesangial proliferation and increases mRNA and secretion of collagen . Kidney Int 1995; 48: 45-51 .

14.

Doublier S , Seurin D , Fouqueray B et al. Glomerulosclerosis in mice transgenic for human insulin-like growth factor-binding protein-1 . Kidney Int 2000; 57: 2299-2307 .

15.

Grellier P , Sabbah M , Fouqueray B et al. Characterization of insulin-like growth factor binding proteins and regulation of IGFBP3 in human mesangial cells . Kidney Int 1996; 49: 1071-1078 .

16.

Slootweg MC , Ohlsson C , Salles JP et al. Insulin-like growth factor binding proteins-2 and -3 stimulate growth hormone receptor binding and mitogenesis in rat osteosarcoma cells . Endocrinology 1995; 136: 4210-4217 .

17.

Jobin J , Bonjour JP. Measurement of glomerular filtration rate in conscious unrestrained rats with inulin infused by implanted osmotic pumps . Am J Physiol 1985; 248: F734-F738 .

18.

Hall AV , Parbtani A , Clark WF et al. Abrogation of MRL/lpr lupus nephritis by dietary flaxseed . Am J Kidney Dis 1993; 22: 326-332 .

19.

Clark WF , Parbtani A , Philbrick DJ et al. Chronic effects of omega-3 fatty acids (fish oil) in a rat 5/6 renal ablation model . J Am Soc Nephrol 1991; 1: 1343-1353 .

20.

Matsell DG , Bennett T , Armstrong RA et al. Insulin-like growth factor (IGF) and IGF binding protein gene expression in multicystic renal dysplasia . J Am Soc Nephrol 1997; 8: 85-94 .

21.

Lindenbergh-Kortleve DJ , Rosato RR , van Neck JW et al. Gene expression of the insulin-like growth factor system during mouse kidney development . Mol Cell Endocrinol 1997; 132: 81-91 .

22.

Matsell DG , Delhanty PJ , Stepaniuk O et al. Expression of insulin-like growth factor and binding protein genes during nephrogenesis . Kidney Int 1994; 46: 1031-1042 .

23.

Feld S , Hirschberg R. Growth hormone, the insulin-like growth factor system, and the kidney . Endocr Rev 1996; 17: 423-480 .

24.

Schuller AG , Groffen C , van Neck JW et al. cDNA cloning and mRNA expression of the six mouse insulin-like growth factor binding proteins . Mol Cell Endocrinol 1994; 104: 57-66 .

25.

Bruijn JA , Roos A , de Geus B et al. Transforming growth factor-beta and the glomerular extracellular matrix in renal pathology . J Lab Clin Med 1994; 123: 34-47 .

26.

Yoshioka K , Takemura T , Murakami K et al. Transforming growth factor-beta protein and mRNA in glomeruli in normal and diseased human kidneys . Lab Invest 1993; 68: 154-163 .

27.

Coimbra T , Wiggins R , Noh JW et al. Transforming growth factor-beta production in anti-glomerular basement membrane disease in the rabbit . Am J Pathol 1991; 138: 223-234 .

28.

Kopp JB , Factor VM , Mozes M et al. Transgenic mice with increased plasma levels of TGF-beta 1 develop progressive renal disease . Lab Invest 1996; 74: 991-1003 .

29.

Rodriguez-Tarduchy G , Collins MK , Garcia I et al. Insulin-like growth factor-I inhibits apoptosis in IL-3-dependent hemopoietic cells . J Immunol 1992; 149: 535-540 .

30.

Tu W , Cheung PT , Lau YL. Insulin-like growth factor 1 promotes cord blood T cell maturation and inhibits its spontaneous and phytohemagglutinin-induced apoptosis through different mechanisms . J Immunol 2000; 165: 1331-1336 .

31.

Morel-Maroger SL , Killen PD , Chi E et al. The composition of glomerulosclerosis. I. Studies in focal sclerosis, crescentic glomerulonephritis, and membranoproliferative glomerulonephritis . Lab Invest 1984; 51: 181-192 .

32.

Downer G , Phan SH , Wiggins RC. Analysis of renal fibrosis in a rabbit model of crescentic nephritis . J Clin Invest 1988; 82: 998-1006 .

33.

Ziyadeh FN. The extracellular matrix in diabetic nephropathy . Am J Kidney Dis 1993; 22: 736-744 .

34.

Lupia E , Elliot SJ , Lenz O et al. IGF-1 decreases collagen degradation in diabetic NOD mesangial cells: implications for diabetic nephropathy . Diabetes 1999; 48: 1638-1644 .

35.

De Mellow JS , Baxter RC. Growth hormone-dependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates IGF-I-stimulated DNA synthesis in human skin fibroblasts . Biochem Biophys Res Commun 1988; 156: 199-204 .

36.

Park IS , Kiyomoto H , Alvarez F et al. Preferential expression of insulin-like growth factor binding proteins-1, -3, and -5 during early diabetic renal hypertrophy in rats . Am J Kidney Dis 1998; 32: 1000-1010 .

37.

Rajaram S , Baylink DJ , Mohan S. Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions . Endocr Rev 1997; 18: 801-831 .

38.

Kelley KM , Oh Y , Gargosky SE et al. Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics . Int J Biochem Cell Biol 1996; 28: 619-637 .

39.

Ferry RJ, Jr , Cerri RW , Cohen P. Insulin-like growth factor binding proteins: new proteins, new functions . Horm Res 1999; 51: 53-67 .

40.

Wolf E , Lahm H , Wu M et al. Effects of IGFBP-2 overexpression in vitro and in vivo . Pediatr Nephrol 2000; 14: 572-578 .